Financial & competing interests disclosure
Carlo Pozzilli has received honoraria for consultancy or speaking from Sanofi Aventis, Biogen, Bayer Schering and Novartis, and research grants from Merck Serono and Sanofi Aventis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.